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Midterm Results of Management of Aortoiliac Aneu-
rysms with Aortouniiliac Devices
Francis Caputo, Raghuveer Vallabhaneni, Yazan Duwayri,
Brian Rubin, Patrick Geraghty, John Curci, Jeffrey Jim,
Kathleen Raman, Gregorio Sicard, Luis A. Sanchez. Wash-
ington University School of Medicine, St. Louis, MO
Objectives: Commercially available Aortouniiliac (AUI)
devices are most often described as rescue therapy for compli-
cations of endovascular aneurysm repair. They have also been
described to be useful in several settings including ruptured
AAA and difficult aortoiliac anatomy. We report on the
indications and outcomes with AUI devices in a single
center.
Methods: We retrospectively identified all patients
who underwent AUI repair in a single center during a
five-year period. Patients were evaluated for indications
of AUI placement, complications of surgery, and overall
mortality. Patient demographics, indications for proce-
dure, perioperative outcomes and mortality data were
analyzed.
Results: There were 38 patients identified having un-
dergone AUI with femoral-femoral bypass with a mean age
of 75.68.9 years. Cook converters including the Renu
were used in 97% of the cases. The indications were elective
aneurysm repair with anatomic constraints (47%), compli-
cations of previous EVAR (29%), rupture (13%) and aor-
toiliac occlusive disease (11%). Of those patients who un-
derwent elective aneurysm repair 35% had concomitant iliac
aneurysms and 29% had occlusive disease in the aortoiliac
system. Non-aneurysm related mortality was 26% within
the five year period. Of the patients alive, the mean overall
follow-up is 28 (9-62) months. There were no aneurysm
related deaths identified. There was an 18% complication
rate. Of those complications identified, 1 was a major
endoleak requiring secondary intervention. The remaining
complications included femoral wound infections (n3),
femoral-femoral bypass occlusion (n2) and pulmonary
complications (n1).
Conclusions: AUI devices are an effective treatment
for aortoiliac aneurysms with challenging anatomy, rup-
ture, or as rescue endoluminal therapy. They may also
have a role in patients with aortoiliac occlusive disease.
Further research is needed to delineate this patient
subset.
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Rebecka Hultgren, Angelika Horna Strand, Emma
Larsson. Dep. Vasc Surg, Karolinska University Hospital,
Karolinska Institutet, Stockholm, Sweden
Objectives: The high proportion of patients with pop-
liteal arterial aneurysms (PAA) that suffer from abdominal
aortic aneurysms (AAA) 9-64% is wellknown, and a high
proportion of AAA patients also suffer from TAA
(25%).The proportion of persons with concurrent PAA;
AAA and TAA has not been investigated previously. One
major obstacle in the analysis is the poorly established
definitions for PAA and TAA. The primary aim was to
analyse the prevalence of concurrent aneurysms; PAA, TAA
or AAA in a cohort of patients treated for PAA.
Methods: Charts for all persons treated for acute and
elective repair for infrainguinal disease (operation/throm-
bolysis) at the Karolinska University Hospital 2004-2010
were investigated, persons treated for PAA were included
(n70). Diagnosis; AAA: AP maximum diameter 3 cm,
TAA; according to radiological diagnosis. Only treated
PAA are included.
Results: 3/70 were women. Mean age was 71 years
among 29 persons treated for unilateral PAA (41%) vs 73
years in 41 persons treated for bilateral PAA (59%) p0.08.
39/70 had AAA (56%). More patients with bilateral
than unilateral PAA had AAA (68% vs 37%, p0.01). 9/70
had TAA (13%), all with concurrent AAA. 7 (10%) have
TAA, AAA and bilateral PAA, mean age; 79 years, vs 71
years, p0.005.
Conclusions:More than 10% of persons with PAA also
have TAA and AAA, high age increases the risk for concur-
rent aneurysms. An underestimation of the diagnosis TAA
and PAA is highly plausible, and higher prevalence rates of
multilevel aneurysm disease can be expected if special at-
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tention towards screening of these patient groups are un-
dertaken. An enhanced understanding of multilevel aneu-
rysm disease can probably improve the general care of this
patient group.
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Long Term Outcomes after Coverage of the Internal
Iliac Artery without Coil Embolization during Abdom-
inal Aortic Aneurysm Endovascular Repair
Konstantinos Papazoglou1, Giorgos S. Sfyroeras2, Neofy-
tos Zambas1, Konstantinos Konstantinidis1, Stavros Kak-
kos3, Maria Mitka1. 1Euromedica Blue Cross Hospital,
Thessaloniki, Greece; 2Vascular Surgery, Attikon Univer-
sity Hospital, Athens, Greece; 3Department of Vascular
Surgery, University of Patras Medical School, Patras,
Greece
Objectives: When abdominal aortic aneurysms (AAA)
and common iliac artery (CIA) aneurysms undergo endo-
vascular repair, endograft limb extension into the external
iliac artery (EIA) is often necessary. Internal iliac artery
(IIA) is usually embolized to prevent endoleak. However
IIA embolization is associated with longer operative time.
It has been our practice not to routinely coil embolize IIA.
The purpose of this study is to review long term outcomes
with this approach.
Methods: Between April 1997 and June 2010 117
patients (111 men; mean age 70.8 years, range 45-92)
underwent endovascular AAA repair and had IIA coverage
without coil embolization, unilateral in 112 and bilateral in
5 cases. Postoperative computed tomography (CT) scan-
ning was performed at 1, 6, 12 months, and yearly
thereafter.
Results: Preoperative AAA size was a mean 62 mm
(range 35-120), and mean CIA diameter was 37 mm
(range 20-80).Primary technical success was achieved in
108 patients (93.1%). Thirty day mortality was 0.8%
(1/116 patients). A patient presented gluteal skin necro-
sis (0.8%) and 15 buttock claudication (12.9%). Patients
were followed up for 34  31 months (range 1-130), 23
of them for more than 60 months. During follow up 39
patients died (33.3%), in three, death was AAA-related
(including 30-day mortality). Cumulative proportion of
survival was 93%, 84%, 71%, 59%, 53% at 1, 2, 3, 4 and 5
years respectively. Secondary interventions were per-
formed in 19 of 116 patients (16.3%), including three
conversions for failed endografts. Kaplan-Meier esti-
mates revealed freedom from reintervention of 91%,
90%, 83%, 81% and 75% at 1, 2, 3, 4 and 5 years
respectively. Ten patients (8.5%) presented a type II
endoleak during follow up.
Conclusions: Stent-graft coverage of the IIA without
coil embolization is a safe and effective adjunct during the
treatment of aortoiliac aneurysms, with a low incidence of
postoperative complications and reinterventions and ac-
ceptable mid and long term results.
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Hybrid Thoracic Endovascular Aortic Repair
(TEVAR) for Complex Aortic Pathology - Early and
Mid-term outcomes
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Manetta, Alan Hartman, Richard Schutzer, Mihai Rosca,
Kambhampaty Krishnasastry. Surgery, North Shore Long
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Objectives: This study is designed to review our early
andmid-term experience with Hybrid TEVAR for complex
aortic pathology.
Methods: We retrospectively reviewed the prospec-
tively recorded data on our series of high risk patients who
had hybrid thoracic aortic repair at our institution. 26
patients underwent a hybrid aortic repair (Median age 72;
range:42-85 years, 65% men) between June 2004 and July
2010. Survival from all-cause death was determined from
the Social Security Death Index.
Results: Primary technical success was achieved in all
the cases. Overall 31 bypasses were performed for aortic
arch debranching (n18) and 21 for visceral(n8), fol-
lowed by TEVAR. 20(77%) hybrid procedures were staged.
Hybrid TEVAR with Aortic Visceral (Distal)debranching: Inflow
and Recipient Vessels. SMA: Superior Mesenteric Artery
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